Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Rheumatoid Arthritis

  Free Subscription


17.10.2022

6 Ann Rheum Dis
1 Arthritis Res Ther
1 Clin Rheumatol
2 Rheumatol Int


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Rheum Dis

  1. PAPPAS DA, St John G, Etzel CJ, Fiore S, et al
    Response to 'Correspondence on 'Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US
    Ann Rheum Dis. 2022;81:e225.
    PubMed        

  2. ZHENG W, Leong PY, Wei JC
    Correspondence to 'Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry stu
    Ann Rheum Dis. 2022;81:e224.
    PubMed        

  3. KEDOR C, Zernicke J, Feist E
    Response to: 'Correspondence on 'Changing the outcome measures, changing the results? The urgent need of a specific disease activity score to adult-onset Still's disease'' by Muraviov and Muraviova.
    Ann Rheum Dis. 2022;81:e234.
    PubMed        

  4. RUSCITTI P, Stamm TA, Giacomelli R
    Response to: 'Correspondence on 'Changing the outcome measures, changing the results? The urgent need of a specific disease activity score to adult-onset Still's disease'' by Muraviov and Muraviova.
    Ann Rheum Dis. 2022;81:e233.
    PubMed        

  5. MURAVIOV Y, Muraviova L
    Correspondence on 'Changing the outcome measures, changing the results? The urgent need of a specific disease activity score to adult-onset Still's disease'.
    Ann Rheum Dis. 2022;81:e232.
    PubMed        

  6. RUSCITTI P, Bruno F, Berardicurti O, Acanfora C, et al
    Response to: 'Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al' by Ch
    Ann Rheum Dis. 2022;81:e221.
    PubMed        


    Arthritis Res Ther

  7. KROOS S, Kampstra ASB, Toes REM, Slot LM, et al
    Absence of Epstein-Barr virus DNA in anti-citrullinated protein antibody-expressing B cells of patients with rheumatoid arthritis.
    Arthritis Res Ther. 2022;24:230.
    PubMed         Abstract available


    Clin Rheumatol

  8. FAN DD, Tan PY, Jin L, Qu Y, et al
    Bioinformatic identification and validation of autophagy-related genes in rheumatoid arthritis.
    Clin Rheumatol. 2022 Oct 11. pii: 10.1007/s10067-022-06399.
    PubMed         Abstract available


    Rheumatol Int

  9. FEDKOV D, Berghofen A, Weiss C, Peine C, et al
    Efficacy and safety of a mobile app intervention in patients with inflammatory arthritis: a prospective pilot study.
    Rheumatol Int. 2022;42:2177-2190.
    PubMed         Abstract available

  10. CHEN J, He Q, Jiang B, Song W, et al
    Research on primary Sjogren's syndrome in 2004-2021: a Web of Science-based cross-sectional bibliometric analysis.
    Rheumatol Int. 2022;42:2221-2229.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: